Emergent BioSolutions Inc. (EBS)

Emergent BioSolutions Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-8.6	52.6	-190.6	-760.5	-211.6	219.5
Depreciation & Amortization	103.2	105.6	116.2	146.4	147.4	127.9
Stock-Based Compensation	16.6	16.2	18	23.1	45.1	42.4
Other Adjustments	-8	18.6	26.4	455	-12.9	75.4
Change in Receivables	59.9	25.5	-24.4	-21.6	118.1	-16.2
Changes in Inventories	-12.3	-30.3	-24.5	0.6	-57.1	-66.6
Changes in Accounts Payable	-17.4	-8.4	-33	10.6	-14	-1.6
Changes in Accrued Expenses	-7.4	-24.4	-2.3	-61.3	-67.5	-5.2
Changes in Income Taxes Payable	11.3	-1.7	23.3	-16.2	28.7	-31.3
Changes in Unearned Revenue	8.7	5.2	-20.3	5.9	9.6	-31.8
Changes in Other Operating Activities	1.7	11.7	169.9	11.7	-19.9	7.7
Operating Cash Flow	148	170.6	58.7	-206.3	-34.1	320.2
Operating Cash Flow Growth	34.42%	190.63%	-	-	-	-40.36%
Capital Expenditures	-12.6	-13.8	-22.9	-51.6	-115.8	-224.1
Purchases of Investments	-	-5	-	-	-	-
Payments for Business Acquisitions	-	-	-	-	-243.7	-
Proceeds from Business Divestments	0.1	38.2	118.1	270.2	-	-
Other Investing Activities	20	50	30	-6.3	-21.8	-
Investing Cash Flow	7.5	69.4	125.2	212.3	-381.3	-224.1
Short-Term Debt Issued	-	-	65	20	598	-
Short-Term Debt Repaid	-	-	-284.2	-398.8	-	-
Net Short-Term Debt Issued (Repaid)	-	-	-219.2	-378.8	598	-
Long-Term Debt Issued	-	-	219	-	-	-
Long-Term Debt Repaid	-101.8	-108.7	-198.2	-164.6	-33.8	-35.9
Net Long-Term Debt Issued (Repaid)	-101.8	-108.7	20.8	-164.6	-33.8	-35.9
Issuance of Common Stock	1.5	2.2	10.8	10.2	5	15.9
Repurchase of Common Stock	-33.9	-24.9	-	-	-82.1	-106
Net Common Stock Issued (Repurchased)	-32.4	-22.7	10.8	10.2	-77.1	-90.1
Other Financing Activities	-3.7	-5.2	-2.4	-2.5	-5.9	-15
Financing Cash Flow	-147.6	-136.6	-190	-535.7	481.2	-141
Effect of Exchange Rate Changes on Cash and Cash Equivalents	0.8	0.1	-1.2	-1.2	0.5	-0.3
Net Cash Flow	8.7	103.5	-6.1	-530.9	66.3	-45.2
Free Cash Flow	135.4	156.8	35.8	-257.9	-149.9	96.1
Free Cash Flow Growth	-13.65%	337.99%	-	-	-	-75.67%
FCF Margin	20.01%	21.11%	3.43%	-24.58%	-13.41%	5.42%
Free Cash Flow Per Share	2.47	2.77	0.68	-5.04	-2.99	1.78
Levered Free Cash Flow	-35.2	-12.2	-182.6	-1,258	264	-41.4
Unlevered Free Cash Flow	37.05	107.49	61.42	-709.41	-252.86	22.15

Updated Apr 30, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q